PGLNEXT

Welcome to the Brand page for “PGLNEXT”, which is offered here for Medical testing services for diagnostic or treatment purposes; medical screening; dna screening for medical purposes;dna analysis services for scientific and medical research purposes, dna sequencing services, analyzing dna sequences for genetic variations across different sample populations, correlating dna sequence variations of sample populations with data indicating effectiveness of medical treatment of the populations, screening dna sequences to determine the presence or absence of genetic variations that correlate to effectiveness of a proposed medical treatment, confirming or establishing a genetic disorder, mendelian disease gene discovery, and dna analysis services under certification standards; medical testing for medical research purposes, performing exome sequencing services for researchers performing work in connection with human diseases; scientific research services, analyzing biological samples including cells and cell extracts for the presence, absence or abundance of nucleic acid, polypeptide or molecular markers associated with cell identity or differentiation, and identifying cell stage by detecting or measuring cell differentiation markers; medical research; dna analysis services for research; scientific research services;.

Its status is currently believed to be active. Its class is unavailable. “PGLNEXT” is believed to be currently owned by “AMBRY GENETICS CORPORATION”.